Kangstem Biotech Co. Ltd (217730) — Long-term Investment Intensity
Kangstem Biotech Co. Ltd (217730) has a Long-term Investment Intensity of 17.8% as of December 2019. Long-term investments of ₩20.23 Billion represent 17.8% of total assets of ₩113.64 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 217730 total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kangstem Biotech Co. Ltd Long-term Investment Intensity (2016–2019)
This chart shows how Kangstem Biotech Co. Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 17.8%, reflecting long-term investments of ₩20.23 Billion against total assets of ₩113.64 Billion KRW. Also explore 217730 asset base for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Kangstem Biotech Co. Ltd (2016–2019)
The table below presents the year-by-year Long-term Investment Intensity for Kangstem Biotech Co. Ltd from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Kangstem Biotech Co. Ltd market cap and net worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 17.8% | ₩20.23 Billion | ₩113.64 Billion | ▲ +14.1 pp |
| 2018 | 3.7% | ₩2.72 Billion | ₩73.19 Billion | ▼ -1.4 pp |
| 2017 | 5.1% | ₩2.34 Billion | ₩45.91 Billion | ▲ +3.9 pp |
| 2016 | 1.2% | ₩568.82 Million | ₩47.44 Billion | — |